Read More Analyst Ratings News Price Target Stifel Maintains Buy on Intl Game Tech, Raises Price Target to $31 By Benzinga Newsdesk February 7, 11:14 AM Stifel analyst Jeffrey Stantial maintains Intl Game Tech (NYSE:IGT) with a Buy and raises the price target from $27 to $31. IGT
Read More Dividends Earnings News $1000 Invested In T. Rowe Price Gr 20 Years Ago Would Be Worth This Much Today By Benzinga Insights July 17, 4:00 PM T. Rowe Price Gr (NASDAQ:TROW) has outperformed the market over the past 20 years by 1.45% on an… TROW
Read More Biotech General News Neuronetics Announces Continued Momentum From Health Plans For TMS Therapy Coverage By Benzinga Newsdesk November 9, 9:38 AM Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, STIM
Read More Media News Tech Top Stories Apple In Final Stages Of Production Testing New iMacs, Says Gurman: What Investors Should Know By Shanthi Rexaline March 5, 5:47 PM Apple, Inc.’s (NASDAQ: AAPL) loyal fan base can soon expect the next iteration of the company’s iMac desktop computer, Bloomberg AAPL